Growth Metrics

Insulet (PODD) EBT (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -19.40%
Dec 31, 2025 14.17%
Sep 30, 2025 332.39%
Jun 30, 2025 -41.08%
Mar 31, 2025 -56.73%
Dec 31, 2024 34.38%
Sep 30, 2024 62.23%
Jun 30, 2024 -6.92%
Mar 31, 2024 -49.12%
Dec 31, 2023 100.93%
Sep 30, 2023 88.42%
Jun 30, 2023 15.85%
Mar 31, 2023 10.31%
Dec 31, 2022 491.23%
Sep 30, 2022 84.21%
Jun 30, 2022 -223.21%
Mar 31, 2022 -12.28%
Dec 31, 2021 119.74%
Sep 30, 2021 153.52%
Jun 30, 2021 -9,566.67%
Mar 31, 2021 101.62%
Dec 31, 2020 -238.06%
Sep 30, 2020 -22.99%
Jun 30, 2020 769.23%
Mar 31, 2020 -138.24%
Dec 31, 2019 518.18%
Sep 30, 2019 -42.11%
Jun 30, 2019 -59.57%
Mar 31, 2019 -56.73%
Dec 31, 2018 486.18%
Sep 30, 2018 244.88%
Jun 30, 2018 79.49%
Mar 31, 2018 10.23%
Dec 31, 2017 -229.87%
Sep 30, 2017 72.53%
Jun 30, 2017 22.42%
Mar 31, 2017 -10.33%
Dec 31, 2016 -203.49%
Sep 30, 2016 31.15%
Jun 30, 2016 59.66%
Mar 31, 2016 32.66%
Dec 31, 2015 12.05%
Sep 30, 2015 -3.99%
Jun 30, 2015 -65.60%
Mar 31, 2015 -443.17%
Dec 31, 2014 82.28%
Sep 30, 2014 62.75%
Jun 30, 2014 -378.02%
Mar 31, 2014 -129.05%
Dec 31, 2013 87.53%
Sep 30, 2013 -104.64%
Jun 30, 2013 1.26%
Mar 31, 2013 -4.04%
Dec 31, 2012 18.27%
Sep 30, 2012 14.01%
Jun 30, 2012 2.22%
Mar 31, 2012 -3.67%
Dec 31, 2011 -4.79%
Sep 30, 2011 30.18%
Jun 30, 2011 -97.23%
Mar 31, 2011 52.79%
Dec 31, 2010 -72.38%
Sep 30, 2010 11.75%